CD276 and breast cancer: Due to the high upregulation of B7-H3 in cancer tissues compared to very low expression levels in normal tissues, there has been growing interest in leveraging B7-H3 for targeted imaging of breast cancer, particularly through the application of microbubbles conjugated to B7-H3-targeted antibodies [135].